Lake Street Private Wealth’s AstraZeneca AZN Stock Holding History

Lake Street Private Wealth’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-56	Closed	-$11K	–	276
2026 Q1	$11K	Buy	+56	New	+$10.8K	﹤0.01%	268

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Lake Street Private Wealth's AZN Position: Q2 2026 in Review

Lake Street Private Wealth sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 56 shares — an estimated $11K sold.

Lake Street Private Wealth first reported a position in AZN in Q1 2026 and held it in 1 quarter. The position peaked at $11K in Q1 2026. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Lake Street Private Wealth reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Lake Street Private Wealth sold 56 AstraZeneca shares in Q2 2026, an estimated $11K.
Lake Street Private Wealth first reported a position in AstraZeneca in Q1 2026 and held it in 1 quarter.
Lake Street Private Wealth's AstraZeneca position peaked at $11K in Q1 2026.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Lake Street Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.